|
Checking my Novo Nordisk insulin just now I can assure you it is made in the EU. France to be precise.
Country of manufacture can be determined by the batch number on the packaging.
Care to show any info that their main manufacturing locations are the US and Brazil? The latter is shown to be their largest manufacturing location outside of the EU. Personally I'd rather my insulin came from Denmark or France than Brazil.
There aren't any EU Tarrifs.
Tariffs are imposed by the importing country not the exporting one. Many countries (US, members of the EU, Canada, Switzerland, Japan, Norway, Czech Republic, Slovakia, Macau in China) have zero percent tariffs as part of the Pharmaceutical Agreement of the WTO Uruguay Round of TRIPS
A number of WTO members, mainly upper income countries, concluded the Pharmaceutical Tariff Elimination Agreement in 1994. Under this agreement, the parties to the agreement eliminated tariffs on all finished pharmaceutical products as well as on designated active ingredients and manufacturing inputs.
http://haiweb.org/wp-content/uploads/2016/04/ACCISS-Tariff-April2016_FINAL.pdf
Whether or not the UK becomes a signatory to the Pharmaceutical Tariff Elimination Agreement after it leaves the EU, it will still be able to trade with the EU on the basis of a zero tariff for pharmaceutical products. In written evidence to the House of Lords EU External Affairs Subcommittee in February 2017, the Government confirmed that:
The Pharmaceutical Agreement is extended on a Most-Favoured Nation (MFN) basis. This means that signatories extend the tariff eliminations to all WTO members. So, all WTO members enjoy the benefits of tariff free trade to signatory countries irrespective of whether or not they themselves are members. The UK will therefore continue to benefit from the tariff eliminations of negotiating parties and in line with our technical rectification approach, the UK will continue to place zero tariffs on pharmaceutical goods covered by the Agreement.
The impact of Brexit on the pharmaceutical sector - Business, Energy & Industrial Strategy - House of Commons |
|